Olanzapine SPE2D2-24-R-0012 Solicitation   3

Background
The Olanzapine National Contract Solicitation (SPE2D2-24-R-0012) is issued by the government to procure various formulations of Olanzapine, a medication used in the treatment of mental health conditions. The contract aims to ensure a reliable supply of this essential drug to meet the needs of healthcare providers and patients. The solicitation outlines the requirements for manufacturing and delivering specified quantities of Olanzapine over multiple years, reflecting the government's commitment to maintaining adequate pharmaceutical supplies.

Work Details
The contract includes the following items with specified quantities and unit types:

1. **Olanzapine 7.5MG – 30 Count**
- Base Year: 9,932 BT
- Option Year 1: 9,932 BT
- Option Year 2: 9,932 BT
- Option Year 3: 9,932 BT
- Option Year 4: 9,932 BT

2. **Olanzapine 7.5MG – 1000 Count**
- Base Year: 252 BT
- Option Year 1: 252 BT
- Option Year 2: 252 BT
- Option Year 3: 252 BT
- Option Year 4: 252 BT

3. **Olanzapine 10MG – 30 Count**
- Base Year: 20,309 BT
- Option Year 1: 20,309 BT
- Option Year 2: 20,309 BT
- Option Year 3: 20,309 BT
- Option Year 4: 20,309 BT

4. **Olanzapine 10MG – 1000 Count**
- Base Year: 2,641 BT
- Option Year 1: 2,641 BT
- Option Year 2: 2,641 BT
- Option Year 3: 2,641 BT
- Option Year 4: 2,641 BT

5. **Olanzapine 5MG – Various Counts**
Includes multiple counts ranging from base year quantities of:
- Olanzapine (5MG –30 Count): Base Year:19,404 BT
- Olanzapine (5MG –100 Count): Base Year:2,494 BT
... and so forth for other dosages and counts as detailed in the solicitation.

Period of Performance
The contract will have a base year followed by four option years for continued supply.

Place of Performance
The products will be delivered to designated government healthcare facilities across the United States.